This is a popup dialog that overlays the main content of the page. The popup includes a search form to help you find the information you are seeking. Pressing the go back button or using the escape key will close the popup.
This site and the materials herein are directed only to financial advisors or other investment professionals with clients that meet the requirements to participate in private market offerings (generally, an accredited investor, qualified client and/or qualified purchaser), and are not intended to be shown to the general public.
Adams Street’s Michael Taylor, Partner, Co-Investments, shares insights on why adding a private equity co-investment allocation to existing portfolios can be an attractive option.
Private equity co-investments is a strategy that can provide many distinct advantages for those seeking exposure to private market opportunities for a typically all-in lower cost.
By acquiring passive, minority stakes in a range of companies, private equity co-investment strategies participate in the lead GP’s highest conviction ideas while not having to play an active role in the management of the purchased company.
This means private equity co-investment managers can build portfolios that are diversified across sector, geography, and time by partnering with lead GPs with specific skills and experience in a particular sector, be it US technology, European healthcare, or Asia industrials.
Lead GPs typically don’t charge their co-investor partners management or performance fees, making the cost of investing in such a strategy an attractive option.